g.ekstrom
TL2 Moderator · Cali
Contributes reviews on supplier material. Based in Cali.
Joined 1 February 2025 · last posted 18h
91 posts, newest first. Showing up to 150.
-
eGFR fluctuation and the creatinine denominator problem — the long version Replied, post #45 · Clinical › Bloodwork · 27 Jul 2026 · 23 likes On post #41 — agreed on the reasoning, with one qualification. Reference intervals: constructed to contain the central 95% of a reference population, which means one in…
-
Trust level 3 requirements: a clarification — does this still hold? Replied, post #88 · Meta › Announcements · 23 Jul 2026 · 2 likes On post #84 — agreed on the reasoning, with one qualification. Feedback to announcements: if you have feedback on an announced change (not a question, but your…
-
0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #112 · Devices › Syringes & needles · 19 Jul 2026 · 5 likes post #111 answers the question as asked. The question underneath it is different. Needle length: typical lengths for subcutaneous injection are 4-6 mm (short), 8 mm…
-
Journal club: what we got wrong in an earlier session Replied, post #98 · Evidence › Journal club · 19 Jul 2026 · 0 likes This follows post #95 rather than contradicting it. TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not…
-
Why retatrutide discussion here is more cautious than elsewhere — one year on Replied, post #72 · Compounds › Retatrutide · 18 Jul 2026 · 0 likes Dose escalation in the published trials: the protocols started at lower doses and escalated by defined steps. The step sizes are documented and they may or may not…
-
Pooling trials with different estimands Replied, post #100 · Evidence › Meta-analyses · 15 Jul 2026 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Coming back to: Delayed gastric emptying and oral medication absorption: which drugs… Replied, post #10 · Practice › Interactions · 9 Jul 2026 · 1 like Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Tracking a shortage from primary sources rather than rumour Replied, post #91 · Access › Shortages · 8 Jul 2026 · 2 likes Managing an unplanned gap: if a shortage causes a gap in treatment, the questions are how long the gap will be and how that affects your condition. Discussing with your…
-
Why the absence of controlled human data on BPC-157 matters more than people admit Replied, post #55 · Compounds › Repair & healing peptides · 7 Jul 2026 · 0 likes Reading a preclinical wound-healing model: the model shows whether a mechanism is plausible in a specific context. It does not show magnitude of effect in humans, does…
-
Journal club: SUSTAIN 6 and its retinopathy signal Replied, post #21 · Evidence › Journal club · 4 Jul 2026 · 3 likes SURPASS-2 (N Engl J Med 2021): Direct comparison of tirzepatide with semaglutide 1.0 mg. The 1.0 mg dose is not the highest available, which is the central and…
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #18 · Pharmacology › Receptor biology · 14 Jun 2026 · 17 likes On post #14 — agreed on the reasoning, with one qualification. Cross-reactivity and selectivity: the compounds are not perfectly selective for their target receptors.…
-
Packaging that arrived damaged: documenting it properly Replied, post #22 · Sourcing › Logistics · 9 Jun 2026 · 29 likes Tracking stops updating: tracking last updated days ago usually means the package is in transit and will not update until it reaches the next scanning point. No update…
-
Journal club: STEP 1 and the treatment-policy estimand — does this still hold? Replied, post #37 · Evidence › Journal club · 8 Jun 2026 · 1 like Session format: read the paper before posting. The discussion is much better when everyone has. Start with the estimand and population, then methods, then results, then…
-
Reading a trial's population section before its results Replied, post #96 · Evidence › Trials · 7 Jun 2026 · 4 likes Open-label design: unblinded trials admit expectation effects. For weight-loss trials where one arm loses substantial weight and the other does not, complete blinding…
-
Step therapy requirements and how to satisfy them Replied, post #26 · Access › Insurance & coverage · 27 May 2026 · 1 like Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
A fridge failure and how I assessed the contents afterwards Replied, post #10 · Devices › Cold chain · 12 May 2026 · 22 likes post #9 answers the question as asked. The question underneath it is different. For anyone arriving from a search: the marked solution above is the direct answer, and…
-
Follow-up: Tirzepatide and nausea: is the profile genuinely different or just… Replied, post #24 · Compounds › Tirzepatide · 5 May 2026 · 13 likes Nausea profile: some people report tirzepatide as less nausea-prone than semaglutide, others report it as more. The trial reported gastrointestinal effects broadly…
-
Second pass at: Leak-back after withdrawal and whether you lost a meaningful dose Replied, post #12 · Practice › Administration · 3 May 2026 · 4 likes Cold solution and stinging: warming the vial in your hands for a minute before injection reduces the stinging sensation substantially. This is the simplest thing to try…
-
Risk-of-bias tools and the judgement they conceal — does this still hold? Replied, post #3 · marked as the solution · Evidence › Meta-analyses · 2 May 2026 · 8 likes Publication bias: what did not get published? Small studies with negative results are less likely to be published than large studies with positive results. A forest…
-
[2026 update] Composite endpoints and the component doing the work Replied, post #86 · Evidence › Trials · 26 Apr 2026 · 0 likes I read post #84 twice before replying, because I had assumed the opposite. Risk of bias: structured appraisal of internal validity. Key things to assess: randomisation…
-
[2026 update] 0.3 mL versus 0.5 mL versus 1 mL barrels: resolution matters Replied, post #30 · Devices › Syringes & needles · 14 Apr 2026 · 19 likes Worth separating two things that post #26 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
Follow-up: State-level differences that actually matter Replied, post #94 · Regional › North America · 9 Apr 2026 · 2 likes United States: FDA licenses compounds. Prescribing and pharmacy practice are state-regulated. Compounds are prescription-only. Coverage is decided by individual plans,…
-
Follow-up: Lyophilisation and why the cake looks the way it does Replied, post #11 · Pharmacology › Formulation chemistry · 30 Mar 2026 · 31 likes Antioxidants: compounds that prevent oxidation (which damages peptides) are sometimes included. Methionine oxidation is a common degradation pathway and antioxidants…
-
Preprint servers and what screening they do Replied, post #104 · Evidence › Preprints · 27 Mar 2026 · 15 likes Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather than quietly editing. The correction was fair and I had…
-
Validating a calculator against hand arithmetic Replied, post #10 · Data & Tools › Calculators · 8 Mar 2026 · 33 likes Precision and significant figures: the calculators do not round to match your input precision. If you input values to one decimal place, the output might have more. Use…
-
Contributing data without breaching anyone's privacy Replied, post #9 · Data & Tools › Datasets · 2 Mar 2026 · 0 likes How to contribute: if you have longitudinal data you want to add, the format is simple: date, measurement, context. Contact the maintainer of the specific dataset.
-
"Greater than or equal to 99%" as a specification rather than a result Replied, post #140 · Analytics › COA interpretation · 25 Feb 2026 · 0 likes post #139 answers the question as asked. The question underneath it is different. Reading old certificates: if a certificate is dated years ago, the lot it describes…
-
MHRA statements, read directly Replied, post #91 · Regional › UK & Ireland · 17 Feb 2026 · 28 likes post #90 answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Reading an interaction checker output critically Replied, post #112 · Practice › Interactions · 6 Feb 2026 · 6 likes Thyroid medications: semaglutide is associated with a slowing of gastric emptying, which might affect thyroid medication absorption if they are taken very close…
-
Coming back to: Washout: how long is long enough, and for what purpose Replied, post #22 · Pharmacology › Pharmacokinetics · 23 Jan 2026 · 21 likes Fasting requirement for oral semaglutide: food and large fluid volumes reduce absorption. The fasting window (30 minutes before and 30 minutes after) is designed to…
-
Older adults, sarcopenia risk, and the trade-off nobody quantifies Replied, post #78 · Clinical › Special populations · 17 Jan 2026 · 0 likes Gastroparesis: pre-existing severe delayed gastric emptying can worsen with compounds that slow it further. Discussion with a clinician is prudent if this history exists.
-
Price changes over 2025 and 2026, tabulated and dated — does this still hold? Replied, post #61 · Access › Pricing · 13 Jan 2026 · 3 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #54 · Compounds › Semaglutide · 10 Jan 2026 · 2 likes Worth separating two things that post #50 runs together. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly rather…
-
[2026 update] Availability by country, dated, with primary sources Replied, post #10 · Access › International · 9 Jan 2026 · 13 likes Import rules for personal use: what you can import for personal use depends on your country's rules, not on where it is sold. Checking your country's rules before…
-
Reconstitution volumes that produce round numbers, tabulated Replied, post #20 · Practice › Reconstitution · 5 Jan 2026 · 6 likes Why "add 2 mL" is not an instruction: the powder in the vial takes up space. "Add 2 mL to a 10 mL vial" and "add 2 mL of diluent so the final volume is approximately 2…
-
Amylin analogue mechanism: satiety signalling separate from GLP-1 — does this still hold? Replied, post #18 · Compounds › Cagrilintide & amylin analogues · 24 Dec 2025 · 28 likes What is genuinely unknown about long-term amylin agonism: real-world response rates, whether effect is durable with continued use, whether satiety adaptation occurs…
-
Meeting a protein target on a suppressed appetite Replied, post #43 · Nutrition & Training › Protein & intake · 18 Dec 2025 · 2 likes Protein sources: animal sources (meat, fish, eggs, dairy) are denser and easier to hit targets with. Plant sources require higher volume. Neither is nutritionally…
-
Why one laboratory's 98.4% and another's 96.1% may not contradict Replied, post #35 · Analytics › Method validation · 17 Dec 2025 · 16 likes This follows post #32 rather than contradicting it. System suitability: injections run at the start of a batch to establish that the instrument and column are…
-
Half-life, steady state, and accumulation worked through — a second dataset Replied, post #35 · Pharmacology › Pharmacokinetics · 10 Dec 2025 · 0 likes post #34 is right about the mechanism and I think understates the practical bit. Fasting requirement for oral semaglutide: food and large fluid volumes reduce…
-
Tracking a preprint to publication: a worked example Replied, post #57 · Evidence › Preprints · 5 Dec 2025 · 32 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
The nausea timeline across the first four weeks, with a tabulated log — what changed since Replied, post #19 · Practice › Side effects · 29 Nov 2025 · 0 likes Nausea: the most common side effect and the most dose- and titration-dependent one. It is usually most prominent in the first 24 to 48 hours after injection and…
-
Why an oral GLP-1 agonist is a formulation achievement more than a chemistry one Replied, post #58 · Compounds › Oral incretins · 24 Nov 2025 · 2 likes I read post #56 twice before replying, because I had assumed the opposite. Oral versus injectable exposure: comparing a 14 mg oral dose with a 0.5 mg injectable dose is…
-
Pen dose counters: what a click does and does not guarantee Replied, post #109 · Devices › Pens & autoinjectors · 19 Nov 2025 · 4 likes I read post #107 twice before replying, because I had assumed the opposite. Visibility of the dose: some pens allow you to see the insulin remaining; others do not.…
-
Semaglutide half-life: where the 165 to 184 hour figure comes from Replied, post #48 · Compounds › Semaglutide · 16 Nov 2025 · 17 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Second pass at: The mass-error checker and its intended scope Replied, post #59 · Data & Tools › Calculators · 9 Nov 2025 · 4 likes Titration planning: a calculator that shows you the escalation schedule for different starting and ending doses can help you visualize your path. Actual path might be…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #80 · Practice › Reconstitution · 17 Oct 2025 · 0 likes Foaming during reconstitution: bubbles in the solution are usually just air incorporated during mixing. They usually resolve with gentle warming and time. Persistent…
-
What a purity-only report leaves out Replied, post #46 · Sourcing › Independent verification · 14 Oct 2025 · 17 likes PeptideMeter: purity analysis plus structured, dated supplier verification records. Produces both individual analytical results and verification records assessed over…
-
Aggregated purity results across four services, with caveats — a second dataset Replied, post #28 · Data & Tools › Datasets · 7 Sep 2025 · 2 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #81 · Evidence › Journal club · 6 Sep 2025 · 9 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Follow-up: Journal club: orforglipron phase 2 and the non-peptide question Replied, post #62 · Evidence › Journal club · 31 Aug 2025 · 30 likes PIONEER 6 (N Engl J Med 2019): Cardiovascular safety trial for oral semaglutide, not efficacy. Non-inferiority for safety was met. The trial was not designed to…
-
[2026 update] Does dual agonism explain the effect size, or is it dose? Replied, post #6 · Compounds › Tirzepatide · 25 Aug 2025 · 12 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
High-resolution MS on aggregates and what it can see Replied, post #39 · Analytics › Mass spectrometry · 8 Aug 2025 · 10 likes Purity and identity are different questions: LC-MS establishes that the species at a retention time has the expected mass. It does not establish how much of the sample…
-
Travel coolers and how long they really hold Replied, post #74 · Devices › Cold chain · 7 Aug 2025 · 10 likes Temperature logging: devices that record temperature over time let you confirm cold chain was maintained. Useful if a shipment was delayed or if you are concerned about…
-
A ten-fold dose error caught before injection — one year on Replied, post #4 · Devices › Syringes & needles · 31 Jul 2025 · 0 likes Worth separating two things that post #3 runs together. Reading units correctly: look at the marking from the side, not from above or below. The bottom of the plunger…
-
Coming back to: Amylin analogue mechanism: satiety signalling separate from GLP-1 Replied, post #23 · Compounds › Cagrilintide & amylin analogues · 21 Jul 2025 · 3 likes The dosing interval: cagrilintide's half-life is roughly 7 to 8 days, suitable for weekly dosing. The pharmacokinetics are the reason the dosing schedule makes sense.
-
Specificity, linearity, accuracy, precision, range, robustness — with real criteria — a… Replied, post #11 · Analytics › Method validation · 5 Jul 2025 · 2 likes Range: the concentration range over which the method has been validated. Going outside the validated range is going outside the method's demonstrated performance.
-
Antibiotics and a course of something with delayed emptying Replied, post #69 · Practice › Interactions · 19 Jun 2025 · 0 likes SGLT2 inhibitors: frequently co-administered and relevant to renal and cardiovascular discussion, not to interactions. There is no pharmacokinetic interaction of concern.
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #63 · Access › Insurance & coverage · 11 Jun 2025 · 4 likes post #62 is right about the mechanism and I think understates the practical bit. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
-
Journal club: the CagriSema phase 2 combination paper — a second dataset Replied, post #32 · Evidence › Journal club · 9 Jun 2025 · 15 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
State-level differences that actually matter Replied, post #5 · marked as the solution · Regional › North America · 30 May 2025 · 9 likes Provincial formularies in Canada are published and are the correct source for coverage information. Coverage for weight management is less common than for diabetes.
-
A report I filed that turned out to be wrong, and the correction Replied, post #71 · Sourcing › Vendor reports · 26 May 2025 · 26 likes Pattern across lots: a single result is a data point. Three or four results from the same supplier showing a consistent pattern becomes a record worth discussing. Two…
-
A claim built entirely on a subgroup analysis Replied, post #41 · Evidence › Study critique · 18 May 2025 · 21 likes Coming back to post #39, because the follow-up matters more than the original answer. Bias towards the null and bias away from the null: different criticisms have…
-
Research-use-only labelling: what it means and what it does not — the long version Replied, post #155 · Sourcing › Regulatory · 18 May 2025 · 27 likes Why this category is maintained as documentation, not as recommendations: the goal is factual accuracy and sourcing, not endorsement of any specific regulatory position.
-
DXA precision and the least significant change for lean mass — the long version Replied, post #43 · Outcomes › Body composition · 14 May 2025 · 2 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #81 · Sourcing › Independent verification · 11 May 2025 · 30 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Dizziness on standing: the ordinary explanation first Replied, post #15 · Nutrition & Training › Hydration & electrolytes · 26 Apr 2025 · 2 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ Replied, post #2 · Sourcing › Independent verification · 21 Apr 2025 · 18 likes the opening post answers the question as asked. The question underneath it is different. Thank you for the correction. I have edited my earlier post with a note rather…
-
Validating a calculator against hand arithmetic — what changed since Replied, post #26 · Data & Tools › Calculators · 21 Apr 2025 · 33 likes Reporting bugs: if you notice a calculator giving wrong results, report it in this subcategory. Bugs are fixed when identified.
-
Follow-up: What other technical communities get right that we do not Replied, post #73 · Lounge › Off topic · 20 Apr 2025 · 0 likes For anyone arriving from a search: the marked solution above is the direct answer, and the replies underneath it add the caveats that make it safe to use.
-
Sequence verification for an obscure compound: how it is done Replied, post #5 · Compounds › Other compounds · 2 Apr 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
Why cagrilintide alone is discussed so much less than in combination Replied, post #69 · Compounds › Cagrilintide & amylin analogues · 30 Mar 2025 · 29 likes Historical amylin analogues: pramlintide was the only long-acting amylin analogue licensed for some time and its poor adherence was a known limitation. A weekly…
-
Validating a method you did not develop — does this still hold? Replied, post #142 · Analytics › Method validation · 20 Mar 2025 · 5 likes Why two laboratories may disagree: after validating the same method, they may still report different purity on the same sample due to integration differences, column…
-
When "no data" is the complete and final answer Replied, post #123 · Compounds › Other compounds · 19 Mar 2025 · 0 likes Compounds this community declines to help with, and why: there are specifics in the guidelines and they are not arbitrary. They exist because of failure modes that have…
-
One lot is one lot: when a report becomes a pattern — the long version Replied, post #31 · Sourcing › Vendor reports · 15 Mar 2025 · 9 likes Disputed records: when a result disagreed and was not explained, the record says disputed and stays that way. We do not remove inconvenient history; we document it.
-
What the published dose-response for semaglutide actually looks like above 2.4 mg — a… Replied, post #100 · Compounds › Semaglutide · 14 Mar 2025 · 20 likes post #99 answers the question as asked. The question underneath it is different. The STEP programme populations were selected: enrollment criteria required baseline…
-
Charge states for a 4 kDa peptide, worked through Replied, post #79 · Analytics › Mass spectrometry · 11 Mar 2025 · 31 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Splitting a vial for two laboratories: how to do it without ruining both Started this topic · Sourcing › Independent verification · 5 Mar 2025 · 24 likes Splitting a vial for two laboratories: how to do it without ruining both — setting out what I have, and where I think it stops being reliable. A logistics question,…
-
Revisiting: Bug report: the reconstitution calculator and a rounding edge case Replied, post #99 · Data & Tools › Calculators · 21 Feb 2025 · 0 likes Picking up post #96: that is the part I would want checked first. Titration planning: a calculator that shows you the escalation schedule for different starting and…
-
A page that has drifted out of date and needs a maintainer Replied, post #60 · Documentation › Wiki requests · 5 Feb 2025 · 15 likes Cross-referencing: if you notice two pages that should reference each other but do not, suggest the cross-reference.
-
Coming back to: Adsorption to container surfaces and to plastics Replied, post #2 · Pharmacology › Formulation chemistry · 5 Jan 2025 · 15 likes Picking up the opening post: that is the part I would want checked first. Thank you for the correction. I have edited my earlier post with a note rather than silently,…
-
Washout with a one-week half-life: the arithmetic Replied, post #86 · Research Methods › N-of-1 designs · 8 Dec 2024 · 23 likes Washout periods: after stopping a medication, how long does it take for the effect to wash out? For compounds with a week-long half-life, roughly a month is needed to…
-
Time to steady state after a dose increase Replied, post #44 · Pharmacology › Pharmacokinetics · 3 Nov 2024 · 2 likes On post #40 — agreed on the reasoning, with one qualification. Having read the exchange above, I think I was wrong earlier in this topic and I want to say so plainly…
-
When "no data" is the complete and final answer Replied, post #9 · Compounds › Other compounds · 25 Oct 2024 · 24 likes This subcategory exists because some people will research compounds outside the main groups discussed here. The standard of evidence and honesty about its limits…
-
Follow-up: Trifluoroacetate content and its consequences Replied, post #17 · Analytics › Impurities & related substances · 21 Oct 2024 · 3 likes I read post #15 twice before replying, because I had assumed the opposite. Deletion sequences (incomplete coupling during synthesis): lower in mass by one residue.…
-
Splitting a vial for two laboratories: how to do it without ruining both — what changed… Replied, post #104 · Sourcing › Independent verification · 2 Oct 2024 · 1 like Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Blind submission and why it changes minds Replied, post #76 · Sourcing › Independent verification · 2 Oct 2024 · 0 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Identical chromatograms across two different lots Replied, post #31 · Sourcing › Red flags · 30 Sep 2024 · 0 likes Evasion when asked: if a supplier does not clarify when asked specifically for method details, counter-ion form, or batch origin, that itself is a red flag worth…
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #37 · Evidence › Journal club · 7 Sep 2024 · 30 likes On post #33 — agreed on the reasoning, with one qualification. Critical appraisal template: (1) What did the trial set out to estimate? (2) Could the design answer that…
-
Promotion criteria, and the one that stops most nominations Replied, post #54 · Documentation › Doc review · 5 Sep 2024 · 26 likes Review of promoted topics: when a topic is nominated for promotion to a maintained documentation page, the draft is posted here. Community review happens before…
-
Splitting a weekly dose in two: the pharmacokinetic argument against — the long version Replied, post #97 · Practice › Dosing & titration · 9 Jul 2024 · 15 likes When a dose reduction is the correct response to a side effect: if a side effect is dose-dependent (nausea, constipation, injection discomfort), reducing the dose is a…
-
Assessing a warm arrival: the decision process — one year on Replied, post #130 · Sourcing › Logistics · 2 Jun 2024 · 7 likes Documentation after arrival: photograph the parcel and its contents on arrival. If something later turns out wrong (damage, loss, wrong item) you have evidence of the…